Marshall Wace North America’s Avantax, Inc. Common Stock AVTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-25,287
Closed -$661K 1686
2019
Q4
$661K Sell
25,287
-287,746
-92% -$6.44M ﹤0.01% 787
2019
Q3
$6.77M Buy
313,033
+231,303
+283% +$5.83M 0.04% 311
2019
Q2
$2.48M Buy
81,730
+28,926
+55% +$952K 0.02% 514
2019
Q1
$1.76M Buy
+52,804
New +$1.54M 0.01% 543
2018
Q4
Sell
-26,987
Closed -$1.09M 1687
2018
Q3
$1.09M Sell
26,987
-90,883
-77% -$3.31M 0.01% 597
2018
Q2
$4.36M Buy
+117,870
New +$3.8M 0.02% 548
2013
Q3
Sell
-55,023
Closed -$1.02M 728
2013
Q2
$1.02M Buy
+55,023
New +$935K 0.08% 226

Other funds holding AVTA

Marshall Wace North America's AVTA Position: Q1 2020 in Review

Marshall Wace North America sold out of Avantax, Inc. Common Stock (AVTA) in Q1 2020, closing a stake of 25,287 shares — an estimated $661K sold.

Marshall Wace North America first reported a position in AVTA in Q2 2013 and held it in 7 quarters. The position peaked at $6.77M in Q3 2019. 154 funds tracked by Wall St. Rank hold AVTA as of Q1 2020.

  • Marshall Wace North America reported no remaining Avantax, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Marshall Wace North America sold 25,287 Avantax, Inc. Common Stock shares in Q1 2020, an estimated $661K.
  • Marshall Wace North America first reported a position in Avantax, Inc. Common Stock in Q2 2013 and held it in 7 quarters.
  • Marshall Wace North America's Avantax, Inc. Common Stock position peaked at $6.77M in Q3 2019.
  • 154 funds tracked by Wall St. Rank held Avantax, Inc. Common Stock as of Q1 2020.

Based on Marshall Wace North America's 13F filing for Q1 2020, filed 15 May 2020.